المؤلفون: Craig S.

مصطلحات الفهرس: thiamine, alcohol blood level, alcohol consumption, article, case report, catheter infection, cerebellum injury/co [Complication], conservative treatment, disease course, drug absorption, drug blood level, drug overdose/di [Diagnosis], drug overdose/th [Therapy], emergency ward, endotracheal intubation, hemoperfusion, hospital discharge, human, intestine lavage, male, neurological complication/co [Complication], neurotoxicity, priority journal, seizure/dt [Drug Therapy], self poisoning, sepsis/dt [Drug Therapy], treatment outcome, unconsciousness, vomiting/dt [Drug Therapy], activated carbon, ceftriaxone/cb [Drug Combination], ceftriaxone/dt [Drug Therapy], diazepam/dt [Drug Therapy], diazepam/iv [Intravenous Drug Administration], flucloxacillin/cb [Drug Combination], flucloxacillin/dt [Drug Therapy], golytely, metoclopramide/dt [Drug Therapy], metoclopramide/iv [Intravenous Drug Administration], phenytoin/cr [Drug Concentration], phenytoin/to [Drug Toxicity], phenytoin/pk [Pharmacokinetics], sodium chloride, adult, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32568
Click here for full text options
LibKey Link

المؤلفون: Gordon J., Holmes L., Morrow J., Robert-Gnansia E., Scheuerle A., Vajda F., Wide K., Tomson T., Battino D., French J., Harden C.

مصطلحات الفهرس: cigarette smoking, cleft lip, cleft lip face palate, cognition, congenital heart malformation, congenital malformation, data analysis, disease association, disease registry, drug industry, epilepsy/dt [Drug Therapy], first trimester pregnancy, human, information processing, informed consent, labor, licence, maternal behavior, medical research, methodology, neural tube defect, patient care, patient selection, pharmacogenetics, pregnancy, pregnancy outcome, prenatal drug exposure, research subject, Sweden, teratogenicity, treatment outcome, anticonvulsive agent/dt [Drug Therapy], anticonvulsive agent/to [Drug Toxicity], carbamazepine/cm [Drug Comparison], carbamazepine/dt [Drug Therapy], carbamazepine/to [Drug Toxicity], etiracetam/dt [Drug Therapy], etiracetam/to [Drug Toxicity], oxcarbazepine/dt [Drug Therapy], oxcarbazepine/to [Drug Toxicity], phenobarbital/dt [Drug Therapy], phenobarbital/to [Drug Toxicity], phenytoin/dt [Drug Therapy], phenytoin/to [Drug Toxicity], valproic acid/cm [Drug Comparison], valproic acid/dt [Drug Therapy], valproic acid/to [Drug Toxicity], outcome assessment, alcohol consumption, article, Article

URL: Click here for full text options
LibKey Link

المؤلفون: Craig S.

مصطلحات الفهرس: drug half life, drug intoxication/di [Diagnosis], drug intoxication/et [Etiology], drug solubility, electrocardiogram, follow up, heart arrhythmia/co [Complication], hemodialysis, hemofiltration, hemoperfusion, human, hypersensitivity reaction/di [Diagnosis], hypersensitivity reaction/si [Side Effect], hypotension/co [Complication], intensive care unit, nausea, nystagmus, peripheral neuropathy/si [Side Effect], peritoneal dialysis, plasmapheresis, priority journal, respiration depression/co [Complication], review, risk factor, seizure/co [Complication], seizure/dt [Drug Therapy], stomach emptying, stomach lavage, symptom, trigeminus neuralgia/dt [Drug Therapy], vomiting/dt [Drug Therapy], acetylsalicylic acid/cb [Drug Combination], acetylsalicylic acid/it [Drug Interaction], activated carbon, anticonvulsive agent/ae [Adverse Drug Reaction], anticonvulsive agent/cb [Drug Combination], anticonvulsive agent/cr [Drug Concentration], anticonvulsive agent/do [Drug Dose], anticonvulsive agent/it [Drug Interaction], anticonvulsive agent/dt [Drug Therapy], anticonvulsive agent/to [Drug Toxicity], anticonvulsive agent/iv [Intravenous Drug Administration], anticonvulsive agent/po [Oral Drug Administration], anticonvulsive agent/pr [Pharmaceutics], anticonvulsive agent/pk [Pharmacokinetics], anticonvulsive agent/pd [Pharmacology], antiemetic agent/dt [Drug Therapy], antineoplastic agent/cb [Drug Combination], antineoplastic agent/it [Drug Interaction], azapropazone/cb [Drug Combination], azapropazone/it [Drug Interaction], benzodiazepine derivative/dt [Drug Therapy], carbamazepine/cb [Drug Combination], carbamazepine/it [Drug Interaction], chlordiazepoxide/cb [Drug Combination], chlordiazepoxide/it [Drug Interaction], cotrimoxazole/cb [Drug Combination], cotrimoxazole/it [Drug Interaction], diazepam/cb [Drug Combination], diazepam/it [Drug Interaction], diltiazem/cb [Drug Combination], diltiazem/it [Drug Interaction], fluconazole/cb [Drug Combination], fluconazole/it [Drug Interaction], imipramine/cb [Drug Combination], imipramine/it [Drug Interaction], isoniazid/cb [Drug Combination], isoniazid/it [Drug Interaction], itraconazole/cb [Drug Combination], itraconazole/it [Drug Interaction], losartan/cb [Drug Combination], losartan/it [Drug Interaction], miconazole/cb [Drug Combination], miconazole/it [Drug Interaction], paroxetine/cb [Drug Combination], paroxetine/it [Drug Interaction], phenobarbital/dt [Drug Therapy], phenytoin/ae [Adverse Drug Reaction], phenytoin/ad [Drug Administration], phenytoin/cb [Drug Combination], phenytoin/cr [Drug Concentration], phenytoin/do [Drug Dose], phenytoin/to [Drug Toxicity], phenytoin/iv [Intravenous Drug Administration], phenytoin/po [Oral Drug Administration], phenytoin/pr [Pharmaceutics], phenytoin/pk [Pharmacokinetics], phenytoin/pd [Pharmacology], pyridoxine/cb [Drug Combination], pyridoxine/it [Drug Interaction], ranitidine/cb [Drug Combination], ranitidine/it [Drug Interaction], thioridazine/cb [Drug Combination], thioridazine/it [Drug Interaction], tolbutamide/cb [Drug Combination], tolbutamide/it [Drug Interaction], unindexed drug, valproic acid/cb [Drug Combination], valproic acid/it [Drug Interaction], verapamil/cb [Drug Combination], verapamil/it [Drug Interaction], vigabatrin/cb [Drug Combination], vigabatrin/it [Drug Interaction], viloxazine/cb [Drug Combination], viloxazine/it [Drug Interaction], QT prolongation, phenytoin/it [Drug Interaction], aspiration, behavior disorder/dt [Drug Therapy], bipolar disorder/dt [Drug Therapy], cerebellum atrophy/co [Complication], cerebellum atrophy/et [Etiology], cerebellum atrophy/si [Side Effect], clinical feature, coma, confusion, convulsion/dt [Drug Therapy], differential diagnosis, drug formulation, Review

URL: Click here for full text options
LibKey Link

المؤلفون: Craig S.

مصطلحات الفهرس: thiamine, alcohol blood level, alcohol consumption, article, case report, catheter infection, cerebellum injury/co [Complication], conservative treatment, disease course, drug absorption, drug blood level, drug overdose/di [Diagnosis], drug overdose/th [Therapy], emergency ward, endotracheal intubation, hemoperfusion, hospital discharge, human, intestine lavage, male, neurological complication/co [Complication], neurotoxicity, priority journal, seizure/dt [Drug Therapy], self poisoning, sepsis/dt [Drug Therapy], treatment outcome, unconsciousness, vomiting/dt [Drug Therapy], activated carbon, ceftriaxone/cb [Drug Combination], ceftriaxone/dt [Drug Therapy], diazepam/dt [Drug Therapy], diazepam/iv [Intravenous Drug Administration], flucloxacillin/cb [Drug Combination], flucloxacillin/dt [Drug Therapy], golytely, metoclopramide/dt [Drug Therapy], metoclopramide/iv [Intravenous Drug Administration], phenytoin/cr [Drug Concentration], phenytoin/to [Drug Toxicity], phenytoin/pk [Pharmacokinetics], sodium chloride, adult, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32568
LibKey Link

المؤلفون: Gordon J., Holmes L., Morrow J., Robert-Gnansia E., Scheuerle A., Vajda F., Wide K., Tomson T., Battino D., French J., Harden C.

مصطلحات الفهرس: cigarette smoking, cleft lip, cleft lip face palate, cognition, congenital heart malformation, congenital malformation, data analysis, disease association, disease registry, drug industry, epilepsy/dt [Drug Therapy], first trimester pregnancy, human, information processing, informed consent, labor, licence, maternal behavior, medical research, methodology, neural tube defect, patient care, patient selection, pharmacogenetics, pregnancy, pregnancy outcome, prenatal drug exposure, research subject, Sweden, teratogenicity, treatment outcome, anticonvulsive agent/dt [Drug Therapy], anticonvulsive agent/to [Drug Toxicity], carbamazepine/cm [Drug Comparison], carbamazepine/dt [Drug Therapy], carbamazepine/to [Drug Toxicity], etiracetam/dt [Drug Therapy], etiracetam/to [Drug Toxicity], oxcarbazepine/dt [Drug Therapy], oxcarbazepine/to [Drug Toxicity], phenobarbital/dt [Drug Therapy], phenobarbital/to [Drug Toxicity], phenytoin/dt [Drug Therapy], phenytoin/to [Drug Toxicity], valproic acid/cm [Drug Comparison], valproic acid/dt [Drug Therapy], valproic acid/to [Drug Toxicity], outcome assessment, alcohol consumption, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31838
LibKey Link

المؤلفون: Craig S.

مصطلحات الفهرس: drug half life, drug intoxication/di [Diagnosis], drug intoxication/et [Etiology], drug solubility, electrocardiogram, follow up, heart arrhythmia/co [Complication], hemodialysis, hemofiltration, hemoperfusion, human, hypersensitivity reaction/di [Diagnosis], hypersensitivity reaction/si [Side Effect], hypotension/co [Complication], intensive care unit, nausea, nystagmus, peripheral neuropathy/si [Side Effect], peritoneal dialysis, plasmapheresis, priority journal, respiration depression/co [Complication], review, risk factor, seizure/co [Complication], seizure/dt [Drug Therapy], stomach emptying, stomach lavage, symptom, trigeminus neuralgia/dt [Drug Therapy], vomiting/dt [Drug Therapy], acetylsalicylic acid/cb [Drug Combination], acetylsalicylic acid/it [Drug Interaction], activated carbon, anticonvulsive agent/ae [Adverse Drug Reaction], anticonvulsive agent/cb [Drug Combination], anticonvulsive agent/cr [Drug Concentration], anticonvulsive agent/do [Drug Dose], anticonvulsive agent/it [Drug Interaction], anticonvulsive agent/dt [Drug Therapy], anticonvulsive agent/to [Drug Toxicity], anticonvulsive agent/iv [Intravenous Drug Administration], anticonvulsive agent/po [Oral Drug Administration], anticonvulsive agent/pr [Pharmaceutics], anticonvulsive agent/pk [Pharmacokinetics], anticonvulsive agent/pd [Pharmacology], antiemetic agent/dt [Drug Therapy], antineoplastic agent/cb [Drug Combination], antineoplastic agent/it [Drug Interaction], azapropazone/cb [Drug Combination], azapropazone/it [Drug Interaction], benzodiazepine derivative/dt [Drug Therapy], carbamazepine/cb [Drug Combination], carbamazepine/it [Drug Interaction], chlordiazepoxide/cb [Drug Combination], chlordiazepoxide/it [Drug Interaction], cotrimoxazole/cb [Drug Combination], cotrimoxazole/it [Drug Interaction], diazepam/cb [Drug Combination], diazepam/it [Drug Interaction], diltiazem/cb [Drug Combination], diltiazem/it [Drug Interaction], fluconazole/cb [Drug Combination], fluconazole/it [Drug Interaction], imipramine/cb [Drug Combination], imipramine/it [Drug Interaction], isoniazid/cb [Drug Combination], isoniazid/it [Drug Interaction], itraconazole/cb [Drug Combination], itraconazole/it [Drug Interaction], losartan/cb [Drug Combination], losartan/it [Drug Interaction], miconazole/cb [Drug Combination], miconazole/it [Drug Interaction], paroxetine/cb [Drug Combination], paroxetine/it [Drug Interaction], phenobarbital/dt [Drug Therapy], phenytoin/ae [Adverse Drug Reaction], phenytoin/ad [Drug Administration], phenytoin/cb [Drug Combination], phenytoin/cr [Drug Concentration], phenytoin/do [Drug Dose], phenytoin/to [Drug Toxicity], phenytoin/iv [Intravenous Drug Administration], phenytoin/po [Oral Drug Administration], phenytoin/pr [Pharmaceutics], phenytoin/pk [Pharmacokinetics], phenytoin/pd [Pharmacology], pyridoxine/cb [Drug Combination], pyridoxine/it [Drug Interaction], ranitidine/cb [Drug Combination], ranitidine/it [Drug Interaction], thioridazine/cb [Drug Combination], thioridazine/it [Drug Interaction], tolbutamide/cb [Drug Combination], tolbutamide/it [Drug Interaction], unindexed drug, valproic acid/cb [Drug Combination], valproic acid/it [Drug Interaction], verapamil/cb [Drug Combination], verapamil/it [Drug Interaction], vigabatrin/cb [Drug Combination], vigabatrin/it [Drug Interaction], viloxazine/cb [Drug Combination], viloxazine/it [Drug Interaction], QT prolongation, phenytoin/it [Drug Interaction], aspiration, behavior disorder/dt [Drug Therapy], bipolar disorder/dt [Drug Therapy], cerebellum atrophy/co [Complication], cerebellum atrophy/et [Etiology], cerebellum atrophy/si [Side Effect], clinical feature, coma, confusion, convulsion/dt [Drug Therapy], differential diagnosis, drug formulation, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32212
LibKey Link